Acquisition Expands National Patient Base and Strengthens Aptiva’s Leadership in Continuous Glucose Monitoring (CGM) Distribution
Aptiva Medical, a Greenleaf Ventures portfolio company and one of the nation’s leading providers of continuous glucose monitoring (CGM) systems, today announced the completion of its acquisition of VeraMed Health.
This transaction significantly expands Aptiva Medical’s patient base, strengthens its referral and payor networks, and accelerates its rapid growth – further reinforcing its leadership in delivering advanced diabetes management solutions to patients across the country.
Greenleaf Ventures, the healthcare-focused private investment firm led by Timothy Stocksdale and David Wallace, has a long track record of building and scaling successful healthcare companies in the medical supply and pharmacy sectors, including Access Diabetic Supply, Arriva Medical, Comfort Medical, and AmerimedRx. Stocksdale and Wallace are also recognized for leading one of the industry’s most notable turnarounds – acquiring Liberty Medical, then the nation’s largest diabetic supply company, out of bankruptcy in 2014, restructuring it, and later selling it to Cardinal Health.
“This acquisition aligns perfectly with Aptiva Medical’s mission to build a leading, nationwide direct-to-patient CGM business,” said David Wallace, Co-Founder and Managing Partner of Greenleaf Ventures. “The VeraMed team has built an excellent foundation of patient care, and Aptiva Medical will ensure a seamless transition for every patient while continuing to raise the bar on service and efficiency.”
